[Treatment of systemic mycoses]. 1987

B Dupont

UI MeSH Term Description Entries
D007108 Immune Tolerance The specific failure of a normally responsive individual to make an immune response to a known antigen. It results from previous contact with the antigen by an immunologically immature individual (fetus or neonate) or by an adult exposed to extreme high-dose or low-dose antigen, or by exposure to radiation, antimetabolites, antilymphocytic serum, etc. Immunosuppression (Physiology),Immunosuppressions (Physiology),Tolerance, Immune
D009181 Mycoses Diseases caused by FUNGI. Fungus Diseases,Fungal Diseases,Fungal Infections,Fungus Infections,Disease, Fungal,Disease, Fungus,Diseases, Fungal,Diseases, Fungus,Fungal Disease,Fungal Infection,Fungus Disease,Fungus Infection,Infection, Fungal,Infection, Fungus,Infections, Fungal,Infections, Fungus
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000935 Antifungal Agents Substances that destroy fungi by suppressing their ability to grow or reproduce. They differ from FUNGICIDES, INDUSTRIAL because they defend against fungi present in human or animal tissues. Anti-Fungal Agents,Antifungal Agent,Fungicides, Therapeutic,Antibiotics, Antifungal,Therapeutic Fungicides,Agent, Antifungal,Anti Fungal Agents,Antifungal Antibiotics

Related Publications

B Dupont
September 1981, Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke,
B Dupont
September 1973, Medicine,
B Dupont
January 1989, The Japanese journal of antibiotics,
B Dupont
April 1973, Rational drug therapy,
B Dupont
January 1978, Scandinavian journal of infectious diseases. Supplementum,
B Dupont
January 1972, Seminars in drug treatment,
B Dupont
January 1978, Scandinavian journal of infectious diseases. Supplementum,
B Dupont
August 1983, Journal of the American Veterinary Medical Association,
B Dupont
May 1974, The Medical clinics of North America,
Copied contents to your clipboard!